We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

2 hedge funds and large institutions have $5.29K invested in Bio-Path Holdings Inc in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 21

91% less funds holding

Funds holding: 22 → 2 (-20)

99% less capital invested

Capital invested by funds: $370K → $5.29K (-$365K)

Holders
2
Holders Change
-20
Holders Change %
-90.91%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$25.7K
2
Jones Financial Companies
Jones Financial Companies
Missouri
+$1

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$276K
2
AWM
Apollon Wealth Management
South Carolina
-$17.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$15.7K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$14.4K
5
TSS
Two Sigma Securities
New York
-$14.2K

BPTH Hedge Fund Activity: Q1 2025 in Review

2 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2025, worth a combined $5.29K — down 99% from $370K a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of BPTH and 2 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $25.7K. The largest seller was Armistice Capital, exiting entirely with an estimated $276K sold.

  • 2 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2025, down from 22 in Q4 2024.
  • Funds reported $5.29K of Bio-Path Holdings Inc stock for Q1 2025, down 99% quarter-over-quarter.
  • 2 funds opened new Bio-Path Holdings Inc positions in Q1 2025 and 21 closed out, a net change of -19 holders.
  • The largest Bio-Path Holdings Inc buyer in Q1 2025 was XTX Topco, an estimated $25.7K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2025 was Armistice Capital, an estimated $276K sold.

Based on aggregated 13F filings for Q1 2025.